Induction of apoptosis by cryptophycin 1, a new antimicrotubule agent

International Journal of Cancer

Volumn 73, Issue 3, 1997, Pages 440-448

  Mooberry, Susan L ^a   Busquets, Lizette ^a   Tien, Georgia ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC ANTIBODY;

ALKYLATION; APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL PROLIFERATION; CHROMATIN CONDENSATION; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERPHASE; MICROTUBULE; PRIORITY JOURNAL; PROTEIN ASSEMBLY;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CYSTEINE ENDOPEPTIDASES; DEPSIPEPTIDES; DNA FRAGMENTATION; DNA, NEOPLASM; ENZYME ACTIVATION; HUMANS; MICROTUBULES; MITOSIS; PEPTIDES, CYCLIC; POLY(ADP-RIBOSE) POLYMERASES; TUMOR CELLS, CULTURED;

EID: 0030670103     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971104)73:3<440::AID-IJC20>3.0.CO;2-F     Document Type: Article

References (26)

1. ALNEMRI, E.S., LIVINGSTON, D.J., NICHOLSON, D.W., SALVESEN, G., THORNBERRY, N.A., WONG, W.W. and YUAN, J., Human ICE/CED-3 protease nomenclature. Cell, 87, 171 (1996).
2. BAI, R., SCHWARTZ, R.E., KEPLER, J.A., PETTIT, G.R. and HAMEL, E., Characterization of the interaction of cryptophycin 1 with tubulin: binding to the Vinca domain, competitive inhibition of Dolastatin 10 binding, and an unusual aggregation reaction. Cancer Res., 56, 4398-4406 (1996).
3. CORBETT, T.H. and 18 OTHERS, Preclinical anticancer activity of cryptophycin 8. J. exp. Ther. Oncol., 1, 95-108 (1996).
4. DARZYNKIEWICZ, Z., BRUNO, S., DEL BINO, G., GORCZYCA, W., HOTZ, M.A., LASSOTA, P. and TRAGANOS, F., Features of apoptotic cells measured by flow cytometry. Cytometry, 13, 795-808 (1992).
5. cdc2 coincident with taxol-induced apoptosis. Cell Growth Differentiation, 5, 1041-1050 (1994).
6. DIVE, C. and HICKMANN, J.A., Drug-target interactions: only the first step in the commitment to a programmed cell death, Brit. J. Cancer, 64, 192-196 (1991).
7. FISHER, D.E., Apoptosis in cancer therapy: crossing the threshold. Cell, 78, 539-542 (1994).
8. GAVRIELI, Y., SHERMAN, Y. and BEN-SASSON, S.A., Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol 119, 493-501 (1992).
9. GOLAKOTI, T., OGINO, J., HELTZEL, C.E., LE HUSEBO, T., JENSEN, C.M., LARSEN, L.K., PATTERSON, G.M.L., MOORE, R.E., MOOBERRY, S.L., CORBETT, T.H. and VALERIOTE, F.A., Structure determination, conformational analysis, chemical stability studies, and antitumor evaluation of the cryptophycins. Isolation of 18 new analogs from Nostoc sp. strain GSV 224. J. Amer. chem. Soc., 117, 12030-12049 (1995).
10. JORDAN, M.A., THROWER, D. und WILSON, L., Mechanism of cell proliferation by Vinca alkaloids. Cancer Res., 51, 2212-2222 (1991).
11. JORDAN, M.A., TOSO, R.J., THROWER, D. and WILSON, L., Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations. Proc. nat. Acad. Sci. (Wash.), 90, 9552-9556 (1993).
12. JORDAN, M.A., WENDELL, K., GARDINER, S., DERRY, W.B., COPP, H. and WILSON, L., Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56, 816-825 (1996).
13. KERKSIEK, K., MEJILLANO, M.R., SCHWARTZ, R.E., GEORG, G.I. and HIMES, R.H., Interaction of cryptophycin 1 with tubulin and microtubules. FEBS Lett., 377, 59-61 (1995).
14. KERR, J.F.R., WINTERFORD, C.M. and HARMON, B.V., Apoptosis: its significance in cancer and cancer therapy. Cancer, 73, 2013-2026 (1994).
15. MILAS, L., HUNTER, N.R., KURDOGLU, B., MASON, K.A., MEYN, R.E., STEPHENS, L.C. and PETERS, L.J., Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol. Cancer Chemother. Pharmacol., 35, 297-303 (1995).
16. MITCHISON, T.J. and KIRSCHNER, M., Dynamic instability of microtubule growth. Nature (Lond.), 312, 237-242 (1984).
17. MOOBERRY, S.L., TAOKA, C.R. and BUSQUETS, L., Cryptophscin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the Vinca binding site. Cancer Lett., 107, 53-57 (1996).
18. NICHOLSON, D.W. and 15 OTHERS, Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376, 37-43 (1995).
19. PINES, J. and HUNTER, T., Human cyclins A and B l are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J. Cell Biol., 115, 1-17 (1991).
20. SCHWARTZ, R.E., HIRSCH, C.F., SESIN, D.F., FLOR, J.E., CHARTRAIN, M., FROMTLING, R.E., HARRIS, G.H., SALVATORE, M.J., LIESCH, J.M. and YUDIN, K., Pharmaceuticals from cultured algae. J. indust. Microbiol., 5, 113-124 (1990).
21. SHERWOOD, S.W., SHERIDAN, J.P. and SCHIMKE, R.T., Induction of apoptosis by the anti-tubulin drug colcemid: relationship of mitotic checkpoint control to the induction of apoptosis in HcLa S3 cells. Exp. Cell Res., 215, 373-379 (1994).
22. cdc2 activation required for apoptosis. Science, 263, 1143-1145 (1994).
23. SMITH, C.D. and ZHANG, X., Mechanism of action of cryptophycin: interaction with the Vinca alkaloid domain of tubulin. J. biol. Chem., 271, 6192-6198 (1996).
24. SMITH, C.D., ZHANG, X., MOOBERRY, S.L., PATTERSON, G.M.L. and MOORE, R.E., Cryptophycin: a new antimicrotubule agent active against drug-resistant cells. Cancer Res., 54, 3779-3784 (1994).
25. TRIMURTULU, G., OHTANI, I., PATTERSON, G.M.L., MOORE, R.E., CORBETT, T.H,. VALERIOTE, F.A. and DEMCHIK, L., Total structures of cryptophycins. potent antitumor depsipeptides from the blue-green alga Nostoc sp. strain CSV 224. J. Amer. chem. Soc., 116, 4729-4737 (1994).
26. WILSON, L. and JORDAN, M.A., Microtubule dynamics: taking aim at a moving target. Chem. Biol., 2, 569-573 (1995).